Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Indrayani Biotech's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was -1.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Indrayani Biotech's 3-Year ROIIC % or its related term are showing as below:
BOM:526445's 3-Year ROIIC % is ranked worse than 65.35% of 1010
companies
in the Business Services industry
Industry Median: 5.14
vs BOM:526445: -1.06
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Indrayani Biotech 3-Year ROIIC % Related Terms
Indrayani Biotech 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Indrayani Biotech's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526445 vs CTAS, CPRT, GPN: 3-Year ROIIC % Comparison
For the Specialty Business Services subindustry, Indrayani Biotech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indrayani Biotech 3-Year ROIIC % vs Business Services Industry
For the Business Services industry and Industrials sector, Indrayani Biotech's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Indrayani Biotech's 3-Year ROIIC % falls into.
Indrayani Biotech's 3-Year ROIIC % for the quarter that ended in Mar. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 40.216 (Mar. 2025) - 61.0765056 (Mar. 2022) )
/
( 2419.65 (Mar. 2025) - 447.499 (Mar. 2022) )
=
-20.8605056
/
1972.151
=
-1.06%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Indrayani Biotech (BOM:526445) has a 3-Year ROIIC % of -1.06 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Indrayani Biotech and its competitors. According to the industry distribution chart, Indrayani Biotech ranks #660 out of 1010 companies in the Business Services industry, placing it in the top 65.3%.
Is Indrayani Biotech's 3-Year ROIIC % too high?
Indrayani Biotech's current 3-Year ROIIC % is -1.06. Based on the distribution chart, Indrayani Biotech ranks #660 out of 1010 companies in the Business Services industry, which is below the industry midpoint. Overall, Indrayani Biotech has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's 3-Year ROIIC % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Indrayani Biotech ranks #660 out of 1010 companies for 3-Year ROIIC %. This places Indrayani Biotech in the lower half of its industry. The industry median 3-Year ROIIC % is 5.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Business Services company?
The median 3-Year ROIIC % among Business Services companies is 5.14, based on 1,010 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Indrayani Biotech and its competitors. For the Business Services industry, the median 3-Year ROIIC % is 5.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indrayani Biotech's current 3-Year ROIIC % is -1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.65, compared to a current price of ₹7.86 — trading 81.1% below its estimated fair value. The current 3-Year ROIIC % is -1.06. Indrayani Biotech's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current 3-Year ROIIC % is -1.06 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indrayani Biotech (BOM:526445) Overvalued in 2026?
Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued.
The current stock price of ₹7.86 is trading 81.1% below its estimated GF Value™ of ₹41.65.
GuruFocus considers Indrayani Biotech to be Possible Value Trap.
Key valuation signals for BOM:526445:
3-Year ROIIC %: -1.06
GF Value™: ₹41.65 vs. price of ₹7.86 (81.1% below fair value)
No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
53GF Score
Get the complete analysis for BOM:526445
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526445 has been successfully added to your 
